US Stock MarketDetailed Quotes

Cardiac Biotech Solutions (CBSC)

Watchlist
  • 0.0300
  • -0.0100-25.00%
15min DelayClose Dec 18 15:29 ET
4.96MMarket Cap-3.00P/E (TTM)

Cardiac Biotech Solutions (CBSC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
289.29%45.07K
-69.35%41.4K
0.98%11.16K
-86.54%11.58K
63.89%135.06K
10.42K
27.56K
66.35%11.05K
21.70%86.02K
9.04%82.41K
Operating revenue
289.29%45.07K
-69.35%41.4K
0.98%11.16K
-86.54%11.58K
63.89%135.06K
--10.42K
--27.56K
66.35%11.05K
21.70%86.02K
9.04%82.41K
Cost of revenue
0
0
0
0
0
0
0
0
0
-71.70%42.24K
Gross profit
289.29%45.07K
-69.35%41.4K
0.98%11.16K
-86.54%11.58K
236.24%135.06K
10.42K
197.97%27.56K
134.19%11.05K
42.39%86.02K
154.53%40.17K
Operating expense
-10.63%246.35K
-20.89%1.37M
-19.80%378.33K
-31.92%275.64K
-19.20%1.73M
341.9K
29.66%512.21K
10.90%471.75K
-19.06%404.91K
19.19%2.14M
Selling and administrative expenses
-16.75%211.03K
-8.77%1.2M
-17.48%344.9K
-3.58%253.48K
-20.87%1.31M
---77.84K
29.66%512.21K
-1.74%417.95K
-47.45%262.88K
-7.78%1.66M
-General and administrative expense
-16.75%211.03K
-8.77%1.2M
-17.48%344.9K
-3.58%253.48K
-20.87%1.31M
---77.84K
29.66%512.21K
-1.74%417.95K
-47.45%262.88K
-7.78%1.66M
Research and development costs
59.35%35.32K
-58.74%173.18K
-37.85%33.43K
-84.39%22.17K
-13.50%419.74K
----
----
--53.79K
--142.03K
--485.24K
Operating profit
23.78%-201.28K
16.79%-1.33M
20.30%-367.17K
17.19%-264.06K
24.08%-1.6M
-331.48K
-14.52%-484.65K
-9.52%-460.69K
27.50%-318.88K
-12.35%-2.1M
Net non-operating interest income expense
-24,494.56%-85.84K
-4,103.12%-222.43K
-856.43%-12.05K
72.04%-349
-13.46%-5.29K
-402
60.48%-2.38K
95.49%-1.26K
95.13%-1.25K
99.70%-4.66K
Non-operating interest income
----
----
----
----
--0
----
----
----
----
--542
Non-operating interest expense
24,494.56%85.84K
4,103.12%222.43K
856.43%12.05K
-72.04%349
1.65%5.29K
--402
-60.48%2.38K
-95.49%1.26K
-95.13%1.25K
-99.66%5.21K
Other net income (expense)
96.38K
-526.06%-366.24K
227.62%37.33K
-58.5K
-29.25K
-29.25K
Gain on sale of security
----
---114.93K
--37.33K
----
----
----
----
----
----
----
Special income (charges)
--96.38K
-329.59%-251.31K
--0
--0
---58.5K
---29.25K
--0
---29.25K
----
--0
-Less:Other special charges
---96.38K
329.59%251.31K
----
----
--58.5K
--29.25K
----
--29.25K
----
----
Income before tax
27.86%-190.74K
-15.48%-1.92M
30.40%-341.89K
17.41%-264.41K
21.22%-1.66M
-361.13K
-13.47%-487.03K
-9.50%-491.2K
31.23%-320.13K
66.79%-2.11M
Income tax
Net income
27.86%-190.74K
-15.48%-1.92M
30.40%-341.89K
17.41%-264.41K
21.22%-1.66M
-361.13K
-13.47%-487.03K
-9.50%-491.2K
31.23%-320.13K
66.79%-2.11M
Net income continuous Operations
27.86%-190.74K
-15.48%-1.92M
30.40%-341.89K
17.41%-264.41K
21.22%-1.66M
---361.13K
-13.47%-487.03K
-9.50%-491.2K
31.23%-320.13K
66.79%-2.11M
Minority interest income
Net income attributable to the parent company
27.86%-190.74K
-3.09%-1.68M
30.40%-341.89K
17.41%-264.41K
22.61%-1.63M
-331.88K
-13.47%-487.03K
-9.50%-491.2K
31.23%-320.13K
66.79%-2.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.86%-190.74K
-3.09%-1.68M
30.40%-341.89K
17.41%-264.41K
22.61%-1.63M
-331.88K
-13.47%-487.03K
-9.50%-491.2K
31.23%-320.13K
66.79%-2.11M
Basic earnings per share
0
0.00%-0.01
40.61%-0.0022
0
50.00%-0.01
0
3.06%-0.0035
6.68%-0.0037
40.63%-0.0025
71.43%-0.02
Diluted earnings per share
0
0.00%-0.01
40.61%-0.0022
0
50.00%-0.01
0
3.06%-0.0035
6.68%-0.0037
40.63%-0.0025
71.43%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
Unaudited
--
--
--
--
Unqualified Opinion with Explanatory Notes
(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 289.29%45.07K-69.35%41.4K0.98%11.16K-86.54%11.58K63.89%135.06K10.42K27.56K66.35%11.05K21.70%86.02K9.04%82.41K
Operating revenue 289.29%45.07K-69.35%41.4K0.98%11.16K-86.54%11.58K63.89%135.06K--10.42K--27.56K66.35%11.05K21.70%86.02K9.04%82.41K
Cost of revenue 000000000-71.70%42.24K
Gross profit 289.29%45.07K-69.35%41.4K0.98%11.16K-86.54%11.58K236.24%135.06K10.42K197.97%27.56K134.19%11.05K42.39%86.02K154.53%40.17K
Operating expense -10.63%246.35K-20.89%1.37M-19.80%378.33K-31.92%275.64K-19.20%1.73M341.9K29.66%512.21K10.90%471.75K-19.06%404.91K19.19%2.14M
Selling and administrative expenses -16.75%211.03K-8.77%1.2M-17.48%344.9K-3.58%253.48K-20.87%1.31M---77.84K29.66%512.21K-1.74%417.95K-47.45%262.88K-7.78%1.66M
-General and administrative expense -16.75%211.03K-8.77%1.2M-17.48%344.9K-3.58%253.48K-20.87%1.31M---77.84K29.66%512.21K-1.74%417.95K-47.45%262.88K-7.78%1.66M
Research and development costs 59.35%35.32K-58.74%173.18K-37.85%33.43K-84.39%22.17K-13.50%419.74K----------53.79K--142.03K--485.24K
Operating profit 23.78%-201.28K16.79%-1.33M20.30%-367.17K17.19%-264.06K24.08%-1.6M-331.48K-14.52%-484.65K-9.52%-460.69K27.50%-318.88K-12.35%-2.1M
Net non-operating interest income expense -24,494.56%-85.84K-4,103.12%-222.43K-856.43%-12.05K72.04%-349-13.46%-5.29K-40260.48%-2.38K95.49%-1.26K95.13%-1.25K99.70%-4.66K
Non-operating interest income ------------------0------------------542
Non-operating interest expense 24,494.56%85.84K4,103.12%222.43K856.43%12.05K-72.04%3491.65%5.29K--402-60.48%2.38K-95.49%1.26K-95.13%1.25K-99.66%5.21K
Other net income (expense) 96.38K-526.06%-366.24K227.62%37.33K-58.5K-29.25K-29.25K
Gain on sale of security -------114.93K--37.33K----------------------------
Special income (charges) --96.38K-329.59%-251.31K--0--0---58.5K---29.25K--0---29.25K------0
-Less:Other special charges ---96.38K329.59%251.31K----------58.5K--29.25K------29.25K--------
Income before tax 27.86%-190.74K-15.48%-1.92M30.40%-341.89K17.41%-264.41K21.22%-1.66M-361.13K-13.47%-487.03K-9.50%-491.2K31.23%-320.13K66.79%-2.11M
Income tax
Net income 27.86%-190.74K-15.48%-1.92M30.40%-341.89K17.41%-264.41K21.22%-1.66M-361.13K-13.47%-487.03K-9.50%-491.2K31.23%-320.13K66.79%-2.11M
Net income continuous Operations 27.86%-190.74K-15.48%-1.92M30.40%-341.89K17.41%-264.41K21.22%-1.66M---361.13K-13.47%-487.03K-9.50%-491.2K31.23%-320.13K66.79%-2.11M
Minority interest income
Net income attributable to the parent company 27.86%-190.74K-3.09%-1.68M30.40%-341.89K17.41%-264.41K22.61%-1.63M-331.88K-13.47%-487.03K-9.50%-491.2K31.23%-320.13K66.79%-2.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.86%-190.74K-3.09%-1.68M30.40%-341.89K17.41%-264.41K22.61%-1.63M-331.88K-13.47%-487.03K-9.50%-491.2K31.23%-320.13K66.79%-2.11M
Basic earnings per share 00.00%-0.0140.61%-0.0022050.00%-0.0103.06%-0.00356.68%-0.003740.63%-0.002571.43%-0.02
Diluted earnings per share 00.00%-0.0140.61%-0.0022050.00%-0.0103.06%-0.00356.68%-0.003740.63%-0.002571.43%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --------Unaudited--------Unqualified Opinion with Explanatory Notes
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More